Benchmark Financial Wealth Advisors’s AbbVie ABBV Stock Holding History

Benchmark Financial Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$977K	Buy	3,881 +107	+3%	+$23K	0.24%	55
2026 Q1	$821K	Buy	3,774 +470	+14%	+$104K	0.23%	59
2025 Q4	$755K	Buy	3,304 +168	+5%	+$38.3K	0.22%	60
2025 Q3	$726K	Sell	3,136 -89	-3%	-$18.1K	0.22%	55
2025 Q2	$599K	Buy	3,225 +208	+7%	+$38.7K	0.2%	56
2025 Q1	$632K	Sell	3,017 -54	-2%	-$10.5K	0.24%	53
2024 Q4	$546K	Buy	3,071 +272	+10%	+$50K	0.17%	56
2024 Q3	$553K	Buy	2,799 +720	+35%	+$134K	0.18%	53
2024 Q2	$357K	Buy	2,079 +476	+30%	+$78.8K	0.13%	64
2024 Q1	$292K	Buy	1,603 +138	+9%	+$23.8K	0.11%	67
2023 Q4	$227K	Buy	+1,465	New	+$214K	0.1%	75

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Benchmark Financial Wealth Advisors's ABBV Position: Q2 2026 in Review

Benchmark Financial Wealth Advisors increased its AbbVie (ABBV) stake by 2.8% in Q2 2026, buying an estimated $23K and bringing the position to 3,881 shares worth $977K. The position accounts for 0.24% of the portfolio, ranked #55.

Benchmark Financial Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Benchmark Financial Wealth Advisors held 3,881 shares of AbbVie worth $977K as of Q2 2026.
Benchmark Financial Wealth Advisors bought 107 AbbVie shares in Q2 2026, an estimated $23K.
AbbVie made up 0.24% of Benchmark Financial Wealth Advisors's portfolio in Q2 2026, its #55 holding.
Benchmark Financial Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Benchmark Financial Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.